Humacyte, Inc. (HUMA) Financials

HUMA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 149.4 million 112.4 million
2023-06-30 168.1 million 107.0 million
2023-03-31 183.0 million 101.1 million
2022-12-31 204.3 million 87.4 million

HUMA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.5 million 1.8 million
2023-06-30 -23.1 million 1.8 million
2023-03-31 -19.8 million 1.8 million
2022-12-31 -19.6 million 1.7 million

HUMA Net Income

No data available :(

HUMA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 100.0 million - 19.5 million
2023-06-30 114.6 million - 20.1 million
2023-03-31 131.7 million 16.4 million 18.3 million
2022-12-31 151.9 million 20.3 million 21.8 million

HUMA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 103.4 million
2023-06-30 103.4 million
2023-03-31 103.3 million
2022-12-31 103.2 million

HUMA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 493000 18.6 million 6.1 million -
2023-06-30 485000 20.5 million 3.1 million -
2023-03-31 1.2 million 17.3 million 5.2 million -
2022-12-31 681000 15.0 million 5.8 million -

HUMA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1.3 million
2023-06-30 - 2.0 million
2023-03-31 - 2.1 million
2022-12-31 - 2.1 million

HUMA

Price: $4.41

52 week price:
1.96
5.60

Earnings Per Share: -1.07 USD

P/E Ratio: -4.17

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 166552

Market Capitalization: 343.0 million

Links: